Cargando…
Comparative performance of CDC-modified SARS-CoV-2 real-time PCR assay with four different commercial assays: laboratory-based study
The coronavirus infectious disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viruses. The pandemic has emerged as a global public health crisis, and the threat of fast-spreading of the latest variants of the coronavirus (such as omicron, delta) is rampant....
Autores principales: | Seetha, Dayakar, Ravikumar, Amjesh, Nair, Radhakrishnan R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134141/ https://www.ncbi.nlm.nih.gov/pubmed/35637662 http://dx.doi.org/10.1007/s00580-022-03356-y |
Ejemplares similares
-
Comparison of four commercial SARS-CoV-2 IgG immuno-assays in RT-PCR negative patients with suspect CT findings
por: Van Praet, Jens T., et al.
Publicado: (2020) -
Molecular-based study of scrub typhus in Kerala, South India from 2014 to 2021: a laboratory-based study
por: Seetha, Dayakar, et al.
Publicado: (2023) -
Development of a multiplex RT-PCR for simultaneous diagnosis of human metapneumovirus (HMPV) and human respiratory syncytial virus (HRSV) from clinical specimens
por: Dayakar, Seetha, et al.
Publicado: (2016) -
Comparison of Two Commercial Molecular Tests and a Laboratory-Developed Modification of the CDC 2019-nCoV Reverse Transcriptase PCR Assay for the Detection of SARS-CoV-2
por: Moore, Nicholas M., et al.
Publicado: (2020) -
Development of a Real-Time PCR Assay for the Detection of the Phlebovirus Fermo Virus
por: Calzolari, Mattia, et al.
Publicado: (2023)